Insulet to Announce Q2 2024 Financial Results on August 8

Insulet Corporation, a prominent name in the realm of tubeless insulin pump technology through its Omnipod® product line, has announced that it will release its financial results for the second quarter of 2024 on August 8, 2024, following the closure of the financial markets. On the same day, the company's management will host a conference call at 4:30 p.m. Eastern Time.

The live call can be accessed through a link on the Investor Relations section of Insulet's website under "Events and Presentations." This call will be available for replay afterward. Participants can join the live call by dialing (888) 770-7129 within the United States or (929) 203-2109 for international calls, using the passcode 5904836.

Insulet Corporation, listed on NASDAQ under the ticker symbol PODD, is based in Massachusetts. The company is a trailblazer in the medical device sector, focusing on simplifying the lives of individuals with diabetes and other conditions through their Omnipod product platform. The Omnipod Insulin Management System stands out as an innovative alternative to conventional insulin delivery methods. It features a user-friendly, wearable design, allowing continuous insulin delivery for up to three days without the need for needles.

A highlight of Insulet's offerings is the Omnipod 5 Automated Insulin Delivery System. This system integrates with a continuous glucose monitor to manage blood sugar levels without requiring multiple daily injections or fingersticks. Users in the U.S. can control the system through a compatible personal smartphone or the Omnipod 5 Controller. Additionally, Insulet utilizes its unique Pod design to adapt the Omnipod technology platform for administering non-insulin subcutaneous medications across various therapeutic areas.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!